Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death

Cancer Letters

Volumn 260, Issue 1-2, 2008, Pages 20-27

  Woods, Dori C ^a   Liu, Han Ken ^a   Nishi, Yoshihiro ^b   Yanase, Toshihiko ^b   Johnson, A L ^a  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Apoptosis; Granulosa cell tumors; p53; Proteasome; TRAIL

Indexed keywords

COMPLEMENTARY DNA; PROTEASOME; PROTEIN BAX; PROTEIN P53; RNA 18S; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; GRANULOSA CELL; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OVARY TUMOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 8; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; GRANULOSA CELL TUMOR; HUMANS; MITOCHONDRIA; OLIGOPEPTIDES; PROTEASE INHIBITORS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 38149077447     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.10.016     Document Type: Article

References (32)

1. Schumer S.T., and Cannistra S.A. Granulosa cell tumor of the ovary. J. Clin. Oncol. 21 (2003) 1180-1189
2. Colombo N., Parma G., Zanagnolo V., and Insinga A. Management of ovarian stromal cell tumors. J. Clin. Oncol. 25 (2007) 2944-2951
3. Nishi Y., Yanase T., Mu Y., Oba K., Ichino I., Saito M., Nomura M., Mukasa C., Okabe T., Goto K., Takayanagi R., Kashimura Y., Haji M., and Nawata H. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 142 (2001) 437-445
4. Zhang H., Vollmer M., De Geyter M., Litzistorf Y., Ladewig A., Durrenberger M., Guggenheim R., Miny P., Holzgreve W., and De Geyter C. Characterization of an immortalized human granulosa cell line. Mol. Hum. Reprod. (2000) 146-153
5. Kim K., Fisher M.J., Xu S.-Q., and El-Deiry W.S. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin. Cancer Res. 16 (2000) 335-346
6. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., and Smith C.A. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3 (1995) 673-682
7. Johnson A.L., Ratajczak C., Haugen M.J., Liu H.-K., and Woods D.C. Tumor necrosis factor related apoptosis inducing ligand (TRAIL) expression and activity in hen granulosa cells. Reproduction 133 (2007) 609-613
8. Pan G., O'Rourke K., Chinnaiyan A.M., Gentz R., Ebner R., Ni J., and Dixit V.M. The receptor for the cytotoxic ligand TRAIL. Science 276 (1997) 111-113
9. Pan G., Ni J., Wei Y.-F., Yu G., Gentz R., and Dixit V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277 (1997) 815-818
10. Bridgham J.T., Wilder J.A., Hollocher H., and Johnson A.L. All in the family: evolutionary and functional relationships among death receptors. Cell Death Differ. 10 (2003) 19-25
11. Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., and Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-κB. Immunity 7 (1997) 831-836
12. Bodmer J.L., Holler N., Reynard S., Vinciguerra P., Schneider P., Juo P., Blenis J., and Tschopp J. TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat. Cell Biol. 2 (2000) 241-243
13. Siervo-Sassi R.R., Marrangoni A.M., Feng X., Naoumova N., Winans M., Edwards R.P., and Lokshin A. Physiological and molecular effects of Apo2L/TRAIL and cisplatin in ovarian carcinoma cell lines. Cancer Lett. 190 (2003) 61-72
14. Bao Q., and Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ. 14 (2007) 56-65
15. Imajoh-Ohmi K.T., Sugiyama S., Tanaka K., Omura S., and Kikuchi H. Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells. Biochem. Biophys. Res. Commun. 217 (1995) 1070-1077
16. Fujita E., Mukasa T., Tsukahara T., Arahata K., Omura S., and Momoi T. Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors. Biochem. Biophys. Res. Commun. 224 (1996) 74-79
17. Orlowski R.Z., Eswara J.R., Lanfond-Walker A., Grever M.R., Orlowski M., and Dang C.V. Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor. Cancer Res. 58 (1998) 4342-4348
18. Adams J., Palombella V.J., Sausville E.A., Johnson J., Destree A., Lazarus D.D., Maas J., Pien C.S., Prakash S., and Elliot P.J. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59 (1999) 2615-2622
19. Er E., Oliver L., Cartron P.-F., Juin P., Manon S., and Vallette F.M. Mitochrondria as the target of the pro-apoptotic protein Bax. Biochim. Biophys. Acta 1757 (2006) 1301-1311
20. Lopes U.G., Erhardt P., Yao R., and Cooper G.M. p53-dependent induction of apoptosis by proteasome inhibitors. J. Biol. Chem. 272 (1997) 12893-12896
21. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of the human BAX gene. Cell 80 (1995) 293-299
22. Wu G., Burns T.F., McDonald E.R., Jiang W., Meng R., Krantz I.D., Kao G., Gan D.D., Zhou J.Y., Muschel R., Hamilton S.R., Spinner N.B., Markowitz S., Wu G., and el-Deiry W.S. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat. Genet. 17 (1997) 141-143
23. Wang S., and el-Deiry W.S. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy. Proc. Natl. Acad. Sci. USA 100 (2003) 15095-15100
24. Woods D.C., and Johnson A.L. Protein kinase C activity mediates LH-induced ErbB/Erk signaling in differentiated hen granulosa cells. Reproduction 133 (2007) 733-741
25. Khan Z.A.J., Jonas S.K., Le-Marer N., Patel H., Wharton R.Q., Tarragona A., Ivison A., and Allen-Mersh T.G. p53 Mutations in primary and metastatic tumors and circulating tumor cells from colorectal carcinoma patients. Clinical Cancer Res. 6 (2000) 3499-3504
26. t method. Methods 25 (2001) 402-408
27. el-Deiry W.S. Regulation of p53 downstream genes. Semin. Cancer Biol. 8 (1998) 345-357
28. Saulle E., Petronelli A., Pasquini L., Petrucci E., Mariani G., Biffoni M., Ferretti G., Scambia G., Benedetti-Panici P., Cognetti F., Humphreys R., Peschle C., and Testa U. Proteosome inhibitors sensitize ovarian cells to TRAIL induced apoptosis. Apoptosis 12 (2007) 635-655
29. An W.G., Hwang S.G., Trebel J.B., and Blagoskonny M.V. Pretease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition. Leukemia 14 (2000) 1276-1283
30. Maki G.G., Huibregtse J.M., and Howley P.M. In vivo ubiquitination and proteasome-mediated degradation of p53. Cancer Res. 56 (1996) 2649-2654
31. Blagosklonny M.V., Wu G.S., Omura S., and El-Deiry W.S. Proteasome-dependent regulation of p21WAF1/CIP1 expression. Biochem. Biophys. Res. Commun. 227 (1996) 564-569
32. Dietrich C., Bartsch T., Schanz F., Oesch F., and Wieser R.J. p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-l-leucinyl-l-norleucinal in platelet-derived growth factor-stimulated human fibroblast. Proc. Natl. Acad. Sci. USA 93 (2006) 10815-10819